EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Lands’ Cycle at the Crossroads: Phospholipid Remodelling, Oxidative Stress, Cellular Toxicity, and Therapeutic Targeting

Airam Roggero iD, Marcos H Toyama, Sergio F Sousa iD

ACS Pharmacology & Translational Science · 2025-11-14 · 8 (11) · 3729-3756

DOI: 10.1021/acsptsci.5c00482 ↗

At a glance

Übersichtsarbeit in ACS Pharmacology & Translational Science, published online on 2025-11-03. Written by Airam Roggero and 2 co-authors. Institution: LAQV/REQUIMTEBioSIM, Department of Biomedicine, Medicine Faculty of Porto University, Porto District, Porto 4099-002, Portugal. Cited 27 times so far (Crossref); 267 references. The full text is freely available (open access, CC BY 4.0). Funded by: Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico, Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo, Funda??o para a Ci?ncia e a Tecnologia.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

The Lands cycle is a fundamental process for the continuous renewal of phospholipids in cell membranes, directly influencing their fluidity and functionality. This cycle is particularly active in tissues such as the nervous and immune systems and is crucial for cellular homeostasis. It is implicated in the development of inflammatory, neurodegenerative, and cancerous diseases. The present review discusses the biochemical regulation of the Lands cyclefocusing on phospholipase A2 (PLA2) and lysophospholipid acyltransferase (LPCAT)and its impact on lipid metabolism, cell signaling, and disease. Dysregulation of this cycle has been linked to pathological conditions, including oncogenesis and hepatotoxicity. This suggests that modulation of the cycle may have an effect on inflammatory responses and tumor resistance. Advances in the fields of lipidomics and computational modeling have resulted in a more comprehensive understanding of the Lands cycle, thereby emphasizing its potential as a therapeutic target.

Subjects

Author keywords

acyl transferaseslipid metabolismmembrane remodellingoncogenesisphospholipases

Authors and institutions

  • LAQV/REQUIMTEBioSIM, Department of Biomedicine, Medicine Faculty of Porto University, Porto District, Porto 4099-002, Portugal.
  • BIOMOLPEP, Department of Biology, Institute of Biosciences UNESP/CLP, São Paulo 11330-900, São Vicente, Brazil.
  • Department of Chemical Engineering, Faculty of Science and Technology, University of Coimbra, Coimbra 3004-531, Portugal.

ORCID profiles: Airam Roggero, Sergio F Sousa

Funding

  • Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico
  • Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo
  • Funda??o para a Ci?ncia e a Tecnologia

Cite

APA

Roggero, A., Toyama, M. H., & Sousa, S. F. (2025). Lands’ Cycle at the Crossroads: Phospholipid Remodelling, Oxidative Stress, Cellular Toxicity, and Therapeutic Targeting. ACS Pharmacology & Translational Science, 8(11), 3729-3756. https://doi.org/10.1021/acsptsci.5c00482

Vancouver

Roggero A, Toyama MH, Sousa SF. Lands’ Cycle at the Crossroads: Phospholipid Remodelling, Oxidative Stress, Cellular Toxicity, and Therapeutic Targeting. ACS Pharmacology & Translational Science. 2025;8(11):3729-3756. doi:10.1021/acsptsci.5c00482

BibTeX
@article{Roggero2025,
  author = {Roggero, Airam and Toyama, Marcos H and Sousa, Sergio F},
  title = {Lands’ Cycle at the Crossroads: Phospholipid Remodelling, Oxidative Stress, Cellular Toxicity, and Therapeutic Targeting},
  journal = {ACS Pharmacology & Translational Science},
  year = {2025},
  volume = {8},
  number = {11},
  pages = {3729--3756},
  doi = {10.1021/acsptsci.5c00482}
}
Start for free →